Prejex joins hands with Polybond and WTC Pune to make needleless injections in India, Health News, ET HealthWorld
Syringes and disposable needles are major contributors to toxic waste. Additionally, the fear of needles is a common factor leading to the reluctance of patients in drawing blood and receiving vaccines or intravenous fluids. With needleless injections, the pain factor is eliminated. Moreover, it will drastically cut down the use of disposable syringes, thus adding to the sustainability factor.
Pune: Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond headed by Adit Rathi of Rathi Group, to manufacture needleless injections. This partnership has enabled the shifting of the manufacturing capabilities of the German company from Berlin to Pune, for global distribution.
The Prejex-Polybond factory will make needleless injections to be distributed worldwide.
Syringes and disposable needles are major contributors to toxic waste and their disposal cost is skyrocketing. Additionally, Trypanophobia (fear of needles) is a common factor leading to the reluctance of patients in drawing blood and receiving vaccines or intravenous fluids.
With Prejex’s entry, the pain factor will be eliminated as the medicine will be delivered subcutaneously through the skin. It will also negate cross-contamination, ensuring high levels of safety and hygiene for doctors and patients alike. The patient will also be able to self-inject, reducing visits to the clinic and making healthcare more cost-effective. It will further allow for customised doses and the application of a variety of drugs. The shelf life of the drugs will be considerably increased due to the novel COC polymer syringes and plasticiser. Moreover, needleless injections will drastically cut down on the use of disposable syringes, thus adding to the sustainability factor.
Speaking on the partnership, Niraj Khinvasara, CIO, World Trade Centre, Pune (WTC) said, “Nearly five per cent of the world is diabetic, that is, roughly four and a half to five million people are taking two injections a day. Companies like Prejex can alleviate pain and make life easier for patients.”
Niraj Khinvasara, CIO, WTC, and Sagar Chordia, Chairman, WTC presented to Prejex a data-based analysis highlighting Pune as an industrial hub which includes over 250 German firms. The presentation focused on the decision of Maarten Stuut, MD, Prejex GMBH, and Harold Gerrits, Director, Global Sales and Distribution, to select India, especially Pune, as their preferred destination.
This Foreign Direct Investment (FDI) influx is a massive boost for Pune’s industrial capacity. India has a healthy medical ecosystem, which is a win-win situation for all the parties involved.
Applauding the agreement, Adit Rathi, Managing Director, Polybond India Pvt Ltd, said, “This association is a true example of the ‘Make in India’ movement. Not only will European consumers get the benefit of European innovation combined with competitive Indian costs, but such associations will also accelerate the introduction of innovative products in the Indian Market.”
Currently, two different models of needleless injection are set to be launched
1. The N-Jector Series: Single-dose disposable device where the dose will be ‘pre-charged’ or ‘pre-filled’ in an ampoule and the device can easily be packed and disposed of once the dose has been administered. The device and/or ampoule can both be stored in a refrigerator or at room temperature.
2. The Prejex Multi-Reusable Device: It will go up to 30,000 clicks and will be ideal for home use and/or self-administration. It will be compatible with pre-filled and non-filled ampoules that can be attached easily via a simple twist.
Read more at: